Literature DB >> 1411737

HIV seroprevalence in hospital patients in rural Georgia.

C S Murrill1, K A Kuncl, H R Weeks, B M Whyte, L R Petersen, R S Janssen.   

Abstract

To determine human immunodeficiency virus (HIV) seroprevalence among hospital patients in three rural community-based hospitals in southern Georgia, we anonymously tested patients 15 to 54 years old for antibodies to HIV-1 from residual blood specimens collected for routine diagnostic purposes. Data collected included age, sex, race, hospital service, presenting condition, physician's knowledge of HIV infection status, and discharge diagnosis. Of 1319 patients tested, seven (0.5%, 95% confidence interval = 0.2% to 1.1%) had antibodies to HIV-1. Of those seven, five had HIV infection unsuspected by their physicians, and four had an infectious disease. HIV seroprevalence was 0.5% for both men and women, 1.0% for blacks, and 0.3% for whites. HIV-positive patients were found on all hospital services. These results suggest that in rural southern Georgia hospitals, HIV should be routinely considered in the differential diagnosis of conditions that may be related to HIV. In addition, these data demonstrate a need for medical services or referral networks for HIV-related illnesses and a need for continuing HIV counseling and testing offered by local health departments in rural southern Georgia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1411737     DOI: 10.1097/00007611-199210000-00009

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

1.  Seasonal variation in undiagnosed HIV infection on the general medicine and trauma services of two urban hospitals.

Authors:  Kathleen A Brady; Sheila Berry; Rajan Gupta; Mark Weiner; Barbara J Turner
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

2.  Guidelines for designing rapid assessment surveys of HIV seroprevalence among hospitalized patients. Centers for Disease Control and Prevention.

Authors:  B Schwartländer; R S Janssen; G A Satten; S E Critchley; L R Petersen; T J Dondero
Journal:  Public Health Rep       Date:  1994 Jan-Feb       Impact factor: 2.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.